{"entity":{"type":"insider","cik":"0001671026","url":"/insider/0001671026","json_url":"/insider/0001671026.json","name":"Shukla Sanjay","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":15,"n_filings":13,"first":"2020-02-07","last":"2026-02-04","span_basis":"filed_date"},"name_variants":[{"name":"Shukla Sanjay","source":"filing","n_filings":13,"first_seen":"2020-02-07","last_seen":"2026-02-04"}],"transactions":[{"id":6111065,"accession":"0001193125-26-038007","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-038007","line_url":"/filing/0001193125-26-038007#line-2","is_derivative":false,"issuer_cik":"0001339970","issuer_name":"aTYR PHARMA INC","issuer_ticker":"ATYR","issuer_name_source":null,"issuer_url":"/issuer/0001339970","owner_cik":"0001671026","owner_name":"Shukla Sanjay","owner_url":"/insider/0001671026","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3745.0,"shares_display":"3,745","price_per_share":0.976,"price_display":"0.98","price_state":"stated","total_value":3655.12,"total_display":"3,655.12","shares_owned_after":153553.0,"shares_owned_after_display":"153,553","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-04","filed_date":"2026-02-04","scope":"insider"},{"id":2236942,"accession":"0000950170-24-067666","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-067666","line_url":"/filing/0000950170-24-067666#line-1","is_derivative":false,"issuer_cik":"0001339970","issuer_name":"aTYR PHARMA INC","issuer_ticker":"LIFE","issuer_name_source":null,"issuer_url":"/issuer/0001339970","owner_cik":"0001671026","owner_name":"Shukla Sanjay","owner_url":"/insider/0001671026","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":1.807,"price_display":"1.81","price_state":"stated","total_value":36140.0,"total_display":"36,140.00","shares_owned_after":136548.0,"shares_owned_after_display":"136,548","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-31","filed_date":"2024-06-03","scope":"insider"},{"id":8117441,"accession":"0001209191-23-058377","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-058377","line_url":"/filing/0001209191-23-058377#line-2","is_derivative":false,"issuer_cik":"0001339970","issuer_name":"aTYR PHARMA INC","issuer_ticker":"LIFE","issuer_name_source":null,"issuer_url":"/issuer/0001339970","owner_cik":"0001671026","owner_name":"Shukla Sanjay","owner_url":"/insider/0001671026","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12000.0,"shares_display":"12,000","price_per_share":1.178,"price_display":"1.18","price_state":"stated","total_value":14136.0,"total_display":"14,136.00","shares_owned_after":106173.0,"shares_owned_after_display":"106,173","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-12","filed_date":"2023-12-12","scope":"insider"},{"id":8117437,"accession":"0001209191-23-058377","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-058377","line_url":"/filing/0001209191-23-058377#line-1","is_derivative":false,"issuer_cik":"0001339970","issuer_name":"aTYR PHARMA INC","issuer_ticker":"LIFE","issuer_name_source":null,"issuer_url":"/issuer/0001339970","owner_cik":"0001671026","owner_name":"Shukla Sanjay","owner_url":"/insider/0001671026","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":1.17,"price_display":"1.17","price_state":"stated","total_value":3510.0,"total_display":"3,510.00","shares_owned_after":94173.0,"shares_owned_after_display":"94,173","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-11","filed_date":"2023-12-12","scope":"insider"},{"id":8609512,"accession":"0001209191-23-054976","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-054976","line_url":"/filing/0001209191-23-054976#line-2","is_derivative":false,"issuer_cik":"0001339970","issuer_name":"aTYR PHARMA INC","issuer_ticker":"LIFE","issuer_name_source":null,"issuer_url":"/issuer/0001339970","owner_cik":"0001671026","owner_name":"Shukla Sanjay","owner_url":"/insider/0001671026","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":13578.0,"shares_display":"13,578","price_per_share":1.111,"price_display":"1.11","price_state":"stated","total_value":15085.158,"total_display":"15,085.16","shares_owned_after":91173.0,"shares_owned_after_display":"91,173","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-13","filed_date":"2023-11-13","scope":"insider"},{"id":8609508,"accession":"0001209191-23-054976","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-054976","line_url":"/filing/0001209191-23-054976#line-1","is_derivative":false,"issuer_cik":"0001339970","issuer_name":"aTYR PHARMA INC","issuer_ticker":"LIFE","issuer_name_source":null,"issuer_url":"/issuer/0001339970","owner_cik":"0001671026","owner_name":"Shukla Sanjay","owner_url":"/insider/0001671026","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1422.0,"shares_display":"1,422","price_per_share":1.138,"price_display":"1.14","price_state":"stated","total_value":1618.236,"total_display":"1,618.24","shares_owned_after":77595.0,"shares_owned_after_display":"77,595","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-10","filed_date":"2023-11-13","scope":"insider"},{"id":8404632,"accession":"0001209191-23-043943","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-043943","line_url":"/filing/0001209191-23-043943#line-1","is_derivative":false,"issuer_cik":"0001339970","issuer_name":"aTYR PHARMA INC","issuer_ticker":"LIFE","issuer_name_source":null,"issuer_url":"/issuer/0001339970","owner_cik":"0001671026","owner_name":"Shukla Sanjay","owner_url":"/insider/0001671026","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":2.0149,"price_display":"2.01","price_state":"stated","total_value":30223.5,"total_display":"30,223.50","shares_owned_after":76173.0,"shares_owned_after_display":"76,173","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-28","filed_date":"2023-08-01","scope":"insider"},{"id":6150291,"accession":"0001209191-22-058295","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-058295","line_url":"/filing/0001209191-22-058295#line-1","is_derivative":false,"issuer_cik":"0001339970","issuer_name":"aTYR PHARMA INC","issuer_ticker":"LIFE","issuer_name_source":null,"issuer_url":"/issuer/0001339970","owner_cik":"0001671026","owner_name":"Shukla Sanjay","owner_url":"/insider/0001671026","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":2.1405,"price_display":"2.14","price_state":"stated","total_value":21405.0,"total_display":"21,405.00","shares_owned_after":50798.0,"shares_owned_after_display":"50,798","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-21","filed_date":"2022-11-21","scope":"insider"},{"id":6456327,"accession":"0001209191-22-041230","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-041230","line_url":"/filing/0001209191-22-041230#line-1","is_derivative":false,"issuer_cik":"0001339970","issuer_name":"aTYR PHARMA INC","issuer_ticker":"LIFE","issuer_name_source":null,"issuer_url":"/issuer/0001339970","owner_cik":"0001671026","owner_name":"Shukla Sanjay","owner_url":"/insider/0001671026","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":2.8776,"price_display":"2.88","price_state":"stated","total_value":43164.0,"total_display":"43,164.00","shares_owned_after":40798.0,"shares_owned_after_display":"40,798","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-01","filed_date":"2022-07-06","scope":"insider"},{"id":6776332,"accession":"0001209191-22-002768","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-002768","line_url":"/filing/0001209191-22-002768#line-1","is_derivative":false,"issuer_cik":"0001339970","issuer_name":"aTYR PHARMA INC","issuer_ticker":"LIFE","issuer_name_source":null,"issuer_url":"/issuer/0001339970","owner_cik":"0001671026","owner_name":"Shukla Sanjay","owner_url":"/insider/0001671026","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":6.7613,"price_display":"6.76","price_state":"stated","total_value":33806.5,"total_display":"33,806.50","shares_owned_after":25798.0,"shares_owned_after_display":"25,798","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-07","filed_date":"2022-01-10","scope":"insider"},{"id":5406639,"accession":"0001209191-21-064565","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-064565","line_url":"/filing/0001209191-21-064565#line-1","is_derivative":false,"issuer_cik":"0001339970","issuer_name":"aTYR PHARMA INC","issuer_ticker":"LIFE","issuer_name_source":null,"issuer_url":"/issuer/0001339970","owner_cik":"0001671026","owner_name":"Shukla Sanjay","owner_url":"/insider/0001671026","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":8.575,"price_display":"8.58","price_state":"stated","total_value":21437.5,"total_display":"21,437.50","shares_owned_after":20798.0,"shares_owned_after_display":"20,798","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-15","filed_date":"2021-11-15","scope":"insider"},{"id":5100459,"accession":"0001209191-21-034292","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-034292","line_url":"/filing/0001209191-21-034292#line-1","is_derivative":false,"issuer_cik":"0001339970","issuer_name":"aTYR PHARMA INC","issuer_ticker":"LIFE","issuer_name_source":null,"issuer_url":"/issuer/0001339970","owner_cik":"0001671026","owner_name":"Shukla Sanjay","owner_url":"/insider/0001671026","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":4.01,"price_display":"4.01","price_state":"stated","total_value":40100.0,"total_display":"40,100.00","shares_owned_after":18298.0,"shares_owned_after_display":"18,298","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-18","filed_date":"2021-05-20","scope":"insider"},{"id":4362404,"accession":"0001209191-21-009112","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-009112","line_url":"/filing/0001209191-21-009112#line-2","is_derivative":false,"issuer_cik":"0001339970","issuer_name":"aTYR PHARMA INC","issuer_ticker":"LIFE","issuer_name_source":null,"issuer_url":"/issuer/0001339970","owner_cik":"0001671026","owner_name":"Shukla Sanjay","owner_url":"/insider/0001671026","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":778.0,"shares_display":"778","price_per_share":7.66,"price_display":"7.66","price_state":"stated","total_value":5959.48,"total_display":"5,959.48","shares_owned_after":8298.0,"shares_owned_after_display":"8,298","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-09","filed_date":"2021-02-09","scope":"insider"},{"id":2370326,"accession":"0001209191-20-038463","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-038463","line_url":"/filing/0001209191-20-038463#line-1","is_derivative":false,"issuer_cik":"0001339970","issuer_name":"aTYR PHARMA INC","issuer_ticker":"LIFE","issuer_name_source":null,"issuer_url":"/issuer/0001339970","owner_cik":"0001671026","owner_name":"Shukla Sanjay","owner_url":"/insider/0001671026","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6000.0,"shares_display":"6,000","price_per_share":4.27,"price_display":"4.27","price_state":"stated","total_value":25620.0,"total_display":"25,620.00","shares_owned_after":7291.0,"shares_owned_after_display":"7,291","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-19","filed_date":"2020-06-23","scope":"insider"},{"id":2283690,"accession":"0001209191-20-007719","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-007719","line_url":"/filing/0001209191-20-007719#line-2","is_derivative":false,"issuer_cik":"0001339970","issuer_name":"aTYR PHARMA INC","issuer_ticker":"LIFE","issuer_name_source":null,"issuer_url":"/issuer/0001339970","owner_cik":"0001671026","owner_name":"Shukla Sanjay","owner_url":"/insider/0001671026","role":"Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":745.0,"shares_display":"745","price_per_share":4.03,"price_display":"4.03","price_state":"stated","total_value":3002.35,"total_display":"3,002.35","shares_owned_after":1291.0,"shares_owned_after_display":"1,291","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-07","filed_date":"2020-02-07","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":15,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":12,"open_market":true},{"code":"S","label":"Open-market sale","n":3,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":15},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001339970","name":"aTYR PHARMA INC","url":"/issuer/0001339970","role":"Director, Officer (President and CEO)","n_filings":13,"first_seen":"2020-02-07","last_seen":"2026-02-04"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001671026","retrieved_at":"2026-08-21T11:09:48+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}